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Not an Innocent Finding to Be Ignored!*
Gösta B. Pettersson, MD, PHD,y L. Leonardo Rodriguez, MD,z Eugene H. Blackstone, MDyxI n this issue of iJACC, Topilsky et al. (1) atthe Mayo Clinic present a provocative study onthe clinical outcome of isolated tricuspid regur-
gitation (TR). These authors studied the late out-
comes of patients with isolated TR collected in a
program of TR quantiﬁcation that enrolled patients
with holosystolic TR from 1995 to 2005. In this study,
isolated TR included patients with no other important
valvular or other cardiac disease, but included pa-
tients with atrial ﬁbrillation and elevated right ven-
tricular (RV) systolic pressure to <50 mm Hg. All
underwent a comprehensive echocardiographic study
of cardiac morphology and function, including TRSEE PAGE 1185quantiﬁcation using the proximal isovelocity surface
area (PISA) method. After exclusion of patients with
pulmonary hypertension, overt cause of TR, or a
serious life-limiting illness, 142 patients with isolated
functional TR were identiﬁed: 74 with mild to moder-
ate TR and 68 with severe TR. To address the authors’
objective to study the effect of isolated (functional)
TR on outcomes compared with those of patients hav-
ing trivial TR, 1,972 patients with trivial TR were iden-
tiﬁed during the same period, and from this group, 211
were selected for the study by frequency (not propen-
sity) matching to 5 variables: sex, age within 10 years,
left ventricular (presumably) ejection fraction within
5%, year of diagnosis, and the presence or absence
of atrial ﬁbrillation. Selecting patients with trivial
(rather than no) TR allowed collection of the same*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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this paper to disclose.echocardiographic variables collected from patients
with more severe TR, including estimation of RV sys-
tolic pressure as a surrogate for pulmonary artery
pressure.
The results of this study show that of several
measures collected from 1 clinical and 1 echocardio-
graphic examination, TR quantiﬁcation by regur-
gitant oriﬁce area (PISA) was the most predictive of
adverse outcomes. Although the visual qualitative
estimation of TR severity was useful to identify the
highest risk patients, it was less predictive of out-
comes. Some aspects of the evaluation are note-
worthy. Several modiﬁcations of the PISA method
were made that are not routinely used in daily clinical
practice (2) and not included in American Society of
Echocardiography guidelines (3). RV function was
evaluated qualitatively and by indexes of myocardial
performance (right ventricular index of myocardial
performance or myocardial performance index), but
the investigators did not re-review the echocardio-
grams to measure “more recent methods” of RV
assessment, such as tricuspid annular plane systolic
excursion, lateral annular systolic velocity, and strain
and strain rate.
After the index echocardiographic examination,
the primary authors appear not to have been further
involved in managing the patients; rather, patients
returned to and were treated and followed by other
physicians. Indications for this referral are not
provided, and we therefore presume that these pa-
tients had a clinical indication for their referral to
undergo echocardiography. We do not know how
many were symptomatic, only that symptoms were
more frequent in those with more than trivial TR.
Atrial ﬁbrillation was present in 45% of patients
with trivial TR and 44% of those with mild to
severe TR.
Outcomes were assessed by review of medical re-
cords, follow-up surveys, and telephone interviews.
Endpoints were all-cause mortality and cardiovascu-
lar events (cardiac deaths, including sudden death
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1196and death caused by congestive heart failure). Out-
comes were analyzed from echocardiographic diag-
nosis until death, cardiac surgery, or last follow-up up
to 2010. We must presume the follow-up was 100%
complete unless inability to determine outcome was
another exclusion criterion.
This is a timely paper, further fueling the debate
surrounding the clinical importance of TR and RV
dysfunction and an increasingly aggressive approach
to severe TR. Some even suggest tricuspid annulo-
plasty based only on the diameter of the tricuspid
annulus in patients undergoing surgery for left-sided
heart disease with the potential for developing func-
tional TR (4). In our studies of functional TR sec-
ondary to degenerative mitral valve disease, TR went
hand in hand with RV dysfunction, which was prog-
nostically more important than TR (5,6).
In our practice, symptomatic patients with severe
TR, with or without atrial ﬁbrillation, undergo a series
of studies, including special echocardiographic mea-
sures of RV function, magnetic resonance imaging,
and right and left heart catheterization, all of which
are clinically integrated. Patients are considered for
tricuspid valve surgery if RV function is deemed good
enough for the heart to take advantage of a compe-
tent tricuspid valve. We would carefully look for and
consider any possible cause of TR, be it functional
with a possible forward cause of TR (left-sided heart
disease with pulmonary venous hypertension, pul-
monary disease with increased pulmonary vascular
resistance, pulmonary valve disease, or intrinsic RV
disease), intrinsic structural tricuspid valve disease,
or functional tricuspid valve disease with a possible
cause from the right atrial side (atrial ﬁbrillation or
left-to-right shunts [atrial septal defect]). Any such
cause would be weighed and in principle strengthen
the indication for surgery. Because atrial ﬁbrillation is
a possible cause of TR, we would not categorize TR as
isolated in such a patient. After this diagnostic
workup, our group of patients with isolated func-
tional TR would be very small! However, whether the
authors are right in their use of the “concept of
functional isolated TR” or they are just studying pa-
tients with “isolated TR” is unimportant. The study
does not claim to add to our mechanistic under-
standing of isolated TR. Rather, the fact that 1 clinical
assessment and 1 echocardiogram are this prognosti-
cally predictive makes this paper powerful.That only 12 of 68 patients (18%) with severe TR
underwent surgery becomes disturbing in light of
<40% 10-year survival and suggests that a more
aggressive approach is justiﬁed. Presentation of a
competing risks curve for death and surgery would be
helpful. It would also be instructive to know how
congestive heart failure was handled: Were patients
censored after 1 episode? More careful follow-up
studies are needed to provide more data points for
clinical symptomatology, TR development, tricuspid
valve tethering, RV morphology, function, and he-
modynamics, and studies of effectiveness and dura-
bility of tricuspid valve surgery with regard to these
echocardiographic variables to ﬁnalize our conclusion
that isolated severe TR is a surgical disease and to
recommend revising surgical guidelines. Today, the
American Heart Association/American College of
Cardiology guidelines deem primary TR unresponsive
to medical therapy as a class IIa recommendation for
surgery (7). We have provided data about the efﬁcacy
of tricuspid valve repair for functional TR in patients
with degenerative mitral valve disease; in these pa-
tients, tricuspid valve repair seems to effectively and
durably eliminate TR and improve RV function,
whereas mitral valve surgery alone accomplishes only
a temporary improvement (8).
To us, the right side of the heart is humbling. It is
less well studied and understood than the left. This
includes the interaction between RV morphology and
function and TR, right/left ventricular interaction,
clinical importance of TR, indications for surgery,
surgical techniques for tricuspid valve repair, and
postoperative management. The search for new ways
to repair valves with functional TR is an indication of
the limitations of our present techniques and our
understanding of the tricuspid valve. The authors
represent the echocardiography laboratory with the
greatest conﬁdence in the PISA technique and should
be congratulated on this powerful study. The next
and important step will be to gain further insight into
the roles of RV function and hemodynamics in
informing our management of patients with TR.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Gösta B. Pettersson, Department of Thoracic and
Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid
Avenue, Desk J4-1, Cleveland, Ohio 44195. E-mail:
petterg@ccf.org.RE F E RENCE S1. Topilsky Y, Nkomo VT, Vatury O, et al. Clinical
outcome of isolated tricuspid regurgitation. J Am
Coll Cardiol Img 2014;7:1185–94.2. Rodriguez L, Anconina J, Flachskampf FA,
Weyman AE, Levine RA, Thomas JD. Impact of
ﬁnite oriﬁce size on proximal ﬂow convergence.Implications for Doppler quantiﬁcation of
valvular regurgitation. Circ Res 1992;70:
923–30.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 1 2 , 2 0 1 4 Pettersson et al.
D E C E M B E R 2 0 1 4 : 1 1 9 5 – 7 Editorial Comment
11973. Zoghbi WA, Enriquez-Sarano M, Foster E,
Grayburn PA, Kraft CD, Levine RA, et al. American
Society of Echocardiography. Recommendations
for evaluation of the severity of native valvular
regurgitation with two-dimensional and Doppler
echocardiography. J Am Soc Echocardiogr 2003;
16:780–1.
4. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T.
Secondary tricuspid regurgitation or dilatation:
which should be the criteria for surgical repair?
Ann Thorac Surg 2005;79:127–32.
5. Vargas-Abello LM, Klein AL, Marwick TH, et al.
Understanding right ventricular dysfunction andfunctional tricuspid regurgitation accompanying
mitral valve disease. J Thorac Cardiovasc Surg
2013;145:1234–41.
6. Ye Y, Desai R, Vargas-Abello LM, et al. Effects
of right ventricular morphology and function on
outcomes of patients with degenerative mitral
valve disease. J Thorac Cardiovasc Surg 2014 Mar 1
[E-pub ahead of print].
7. Nishimura RA, Otto CM, Bonow RO, et al. 2014
AHA/ACC guideline for the management of
patients with valvular heart disease: executive
summary: a report of the American College of
Cardiology/American Heart Association Task Forceon Practice Guidelines. J Am Coll Cardiol 2014;
63:2438–88 (erratum in J Am Coll Cardiol 2014;
63:2489).
8. Desai RR, Vargas Abello LM, et al. Tricuspid
regurgitation and right ventricular function after
mitral valve surgery with or without concomitant
tricuspid valve procedure. J Thorac Cardiovasc
Surg 2013;146:1126–32.KEY WORDS effective regurgitant oriﬁce,
isolated tricuspid regurgitation, prognosis,
tricuspid regurgitation
